Brief: Oncocyte Provides Positive Update On Clinical Trial ProgresS
30/04/2025 13:35
April 30 (Reuters) - OncoCyte Corp OCX.O: ONCOCYTE PROVIDES POSITIVE UPDATE ON CLINICAL TRIAL PROGRESS Source text: ID:nGNX9H5Qq8 Further company coverage: OCX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Insight Molecular Diagnostics
See all newsBrief: Insight Molecular Diagnostics Enters Amendment No. 2 To Merger Agreement On Sept 15, 2026
Insight Molecular Diagnostics Inc reports results for the quarter ended June 30 - Earnings Summary
Insight Molecular Diagnostics Inc expected to post a loss of 24 cents a share - Earnings Preview
Insight Molecular Diagnostics Q1 loss narrows as costs drop
Brief: Insight Molecular Diagnostics Completes Key Milestones Advancing Graftassuredx Toward FDA Submission